Deposition of the amyloid beta protein in vessel
walls in the brain and in neuritic plaques is one of
the cardinal features of Alzheimer's disease. There
is no mechanism at present to identify the presence
of amyloid ß protein deposition in living patients.
In this work we are investigating labeled serum
amyloid P component and related compounds in animal
and later human applications.